{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:43:02Z","timestamp":1790962982345,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04786-5","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:53:51Z","timestamp":1764320031000},"page":"6833-6847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transdermal delivery of risedronate via spanlastics for osteoporosis: formulation optimization, skin deposition, and pharmacokinetic assessment"],"prefix":"10.1007","volume":"399","author":[{"given":"Amrendra J.","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-1741","authenticated-orcid":false,"given":"Sarika","family":"Wairkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"4786_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2163321","author":"R Abdelmonem","year":"2023","unstructured":"Abdelmonem R, El-Enin HAA, Abdelkader G, Abdel-Hakeem M (2023) Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment. Drug Deliv. https:\/\/doi.org\/10.1080\/10717544.2022.2163321","journal-title":"Drug Deliv"},{"key":"4786_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102725","author":"E Alaaeldin","year":"2021","unstructured":"Alaaeldin E, Mostafa M, Mansour HF, Soliman GM (2021) Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: fabrication and cytotoxic studies against breast cancer cell lines. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2021.102725","journal-title":"J Drug Deliv Sci Technol"},{"key":"4786_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121614","author":"HI Almohamady","year":"2024","unstructured":"Almohamady HI, Mortagi Y, Gad S et al (2024) Spanlastic nano-vesicles: a novel approach to improve the dissolution, bioavailability, and pharmacokinetic behavior of famotidine. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph17121614","journal-title":"Pharmaceuticals"},{"key":"4786_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100240","author":"BK Almutairy","year":"2024","unstructured":"Almutairy BK, Khafagy ES, Aldawsari MF et al (2024) Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia. Int J Pharm: X. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100240","journal-title":"Int J Pharm: X"},{"key":"4786_CR5","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1081\/JLC-200029351","volume":"27","author":"A Aluoch","year":"2004","unstructured":"Aluoch A, Tatini R, Parsons DM, Sadik O (2004) Stability indicating ion-pair HPLC method for the determination of risedronate in a commercial formulation. J Liq Chromatogr Relat Technol 27:2799\u20132813. https:\/\/doi.org\/10.1081\/JLC-200029351","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"4786_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.mcna.2021.05.016","volume":"105","author":"AK Anam","year":"2021","unstructured":"Anam AK, Insogna K (2021) Update on osteoporosis screening and management. Med Clin North Am 105:1117\u20131134. https:\/\/doi.org\/10.1016\/j.mcna.2021.05.016","journal-title":"Med Clin North Am"},{"key":"4786_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1208\/s12249-022-02217-9","volume":"23","author":"MD Ansari","year":"2022","unstructured":"Ansari MD, Saifi Z, Pandit J et al (2022) Spanlastics a novel nanovesicular carrier: its potential application and emerging trends in therapeutic delivery. AAPS PharmSciTech 23:112. https:\/\/doi.org\/10.1208\/s12249-022-02217-9","journal-title":"AAPS PharmSciTech"},{"key":"4786_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105804","author":"EH Barakat","year":"2024","unstructured":"Barakat EH, Kassem AM, Ibrahim MF et al (2024) Fabrication of prostructured spanlastics gel for improving transdermal effect of dapagliflozin: in vitro characterization studies and in vivo antidiabetic activity. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2024.105804","journal-title":"J Drug Deliv Sci Technol"},{"key":"4786_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bmb\/ldaa005","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM et al (2020) The epidemiology of osteoporosis. Br Med Bull 133:105\u2013117. https:\/\/doi.org\/10.1093\/bmb\/ldaa005","journal-title":"Br Med Bull"},{"key":"4786_CR10","doi-asserted-by":"publisher","unstructured":"Diab DL, Watts NB, Miller PD (2013) Bisphosphonates: pharmacology and use in the treatment of osteoporosis. In: Osteoporosis: fourth edition. Elsevier Inc., pp 1859\u20131872. https:\/\/doi.org\/10.1016\/B978-0-12-813073-5.00074-5","DOI":"10.1016\/B978-0-12-813073-5.00074-5"},{"key":"4786_CR11","doi-asserted-by":"publisher","unstructured":"Dunn CJ, Goa KL, Ankrom MA. Risedronate a review of its pharmacological properties and clinical use in resorptive bone disease. https:\/\/doi.org\/10.2165\/00003495-200161050-00013","DOI":"10.2165\/00003495-200161050-00013"},{"key":"4786_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.xphs.2021.08.023","volume":"111","author":"MA Elgewelly","year":"2022","unstructured":"Elgewelly MA, Elmasry SM, Sayed NSE, Abbas H (2022) Resveratrol-loaded vesicular elastic nanocarriers gel in imiquimod-induced psoriasis treatment: in vitro and in vivo evaluation. J Pharm Sci 111:417\u2013431. https:\/\/doi.org\/10.1016\/j.xphs.2021.08.023","journal-title":"J Pharm Sci"},{"key":"4786_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10717544.2021.1886377","volume":"28","author":"M Elhabak","year":"2021","unstructured":"Elhabak M, Ibrahim S, Abouelatta SM (2021) Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin. Drug Deliv 28:445\u2013453. https:\/\/doi.org\/10.1080\/10717544.2021.1886377","journal-title":"Drug Deliv"},{"key":"4786_CR14","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.2147\/DDDT.S220473","volume":"13","author":"NA El-Nabarawy","year":"2019","unstructured":"El-Nabarawy NA, Teaima MH, Helal DA (2019) Assessment of spanlastic vesicles of zolmitriptan for treating migraine in rats. Drug des Devel Ther 13:3929\u20133937. https:\/\/doi.org\/10.2147\/DDDT.S220473","journal-title":"Drug des Devel Ther"},{"key":"4786_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijpharm.2019.04.069","volume":"564","author":"YSR Elnaggar","year":"2019","unstructured":"Elnaggar YSR, Omran S, Hazzah HA, Abdallah OY (2019) Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. Int J Pharm 564:410\u2013425. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.069","journal-title":"Int J Pharm"},{"key":"4786_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/08982104.2022.2100902","volume":"33","author":"EH Elsaied","year":"2023","unstructured":"Elsaied EH, Dawaba HM, Ibrahim ESA, Afouna MI (2023) Spanlastics gel-a novel drug carrier for transdermal delivery of glimepiride. J Liposome Res 33:102\u2013114. https:\/\/doi.org\/10.1080\/08982104.2022.2100902","journal-title":"J Liposome Res"},{"key":"4786_CR17","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1306-2","author":"AM Fahmy","year":"2019","unstructured":"Fahmy AM, El-Setouhy DA, Habib BA, Tayel SA (2019) Enhancement of transdermal delivery of haloperidol via spanlastic dispersions: entrapment efficiency vs. particle size. AAPS PharmSciTech. https:\/\/doi.org\/10.1208\/s12249-019-1306-2","journal-title":"AAPS PharmSciTech"},{"key":"4786_CR18","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1208\/s12249-017-0771-8","volume":"18","author":"DA Farghaly","year":"2017","unstructured":"Farghaly DA, Aboelwafa AA, Hamza MY, Mohamed MI (2017) Topical delivery of fenoprofen calcium via elastic nano-vesicular spanlastics: optimization using experimental design and in vivo evaluation. AAPS PharmSciTech 18:2898\u20132909. https:\/\/doi.org\/10.1208\/s12249-017-0771-8","journal-title":"AAPS PharmSciTech"},{"key":"4786_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s13346-021-00993-8","volume":"12","author":"AM Fatouh","year":"2022","unstructured":"Fatouh AM, Elshafeey AH, Abdelbary A (2022) Liver targeting of ledipasvir via galactosylated chitosan\u2013coated spanlastics: chemical synthesis, statistical optimization, in vitro, and pharmacokinetic evaluation. Drug Deliv Transl Res 12:1161\u20131174. https:\/\/doi.org\/10.1007\/s13346-021-00993-8","journal-title":"Drug Deliv Transl Res"},{"key":"4786_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/17425247.2013.785518","volume":"10","author":"M Fazil","year":"2013","unstructured":"Fazil M, Ali A, Baboota S et al (2013) Exploring drug delivery systems for treating osteoporosis. Expert Opin Drug Deliv 10:1123\u20131136. https:\/\/doi.org\/10.1517\/17425247.2013.785518","journal-title":"Expert Opin Drug Deliv"},{"key":"4786_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10717544.2013.870259","volume":"22","author":"M Fazil","year":"2015","unstructured":"Fazil M, Baboota S, Sahni JK et al (2015) Bisphosphonates: therapeutics potential and recent advances in drug delivery. Drug Deliv 22:1\u20139. https:\/\/doi.org\/10.3109\/10717544.2013.870259","journal-title":"Drug Deliv"},{"key":"4786_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.aca.2007.07.011","volume":"597","author":"SLC Ferreira","year":"2007","unstructured":"Ferreira SLC, Bruns RE, Ferreira HS et al (2007) Box-behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta 597:179\u2013186. https:\/\/doi.org\/10.1016\/j.aca.2007.07.011","journal-title":"Anal Chim Acta"},{"key":"4786_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124879","author":"CM Gowda","year":"2024","unstructured":"Gowda CM, Wairkar S (2024) Azelaic acid-based lyotropic liquid crystals gel for acne vulgaris: formulation optimization, antimicrobial activity and dermatopharmacokinetic study. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124879","journal-title":"Int J Pharm"},{"key":"4786_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121060","author":"S Gyanewali","year":"2021","unstructured":"Gyanewali S, Kesharwani P, Sheikh A et al (2021) Formulation development and in vitro\u2013in vivo assessment of protransfersomal gel of anti-resorptive drug in osteoporosis treatment. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121060","journal-title":"Int J Pharm"},{"key":"4786_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106556","author":"R Holm","year":"2023","unstructured":"Holm R, Kuentz M, Ilie-Spiridon AR, Griffin BT (2023) Lipid based formulations as supersaturating oral delivery systems: from current to future industrial applications. Eur J Pharm Sci. https:\/\/doi.org\/10.1016\/j.ejps.2023.106556","journal-title":"Eur J Pharm Sci"},{"key":"4786_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105521","author":"Y Hou","year":"2020","unstructured":"Hou Y, Piao H, Tahara Y et al (2020) Solid-in-oil nanodispersions as a novel delivery system to improve the oral bioavailability of bisphosphate, risedronate sodium. Eur J Pharm Sci. https:\/\/doi.org\/10.1016\/j.ejps.2020.105521","journal-title":"Eur J Pharm Sci"},{"key":"4786_CR27","doi-asserted-by":"publisher","first-page":"RC04","DOI":"10.7860\/JCDR\/2015\/13000.6635","volume":"9","author":"S Jhaveri","year":"2015","unstructured":"Jhaveri S, Upashani T, Bhadauria J et al (2015) Current clinical practice scenario of osteoporosis management in India. J Clin Diagn Res 9:RC04\u2013RC08. https:\/\/doi.org\/10.7860\/JCDR\/2015\/13000.6635","journal-title":"J Clin Diagn Res"},{"key":"4786_CR28","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2147\/IJN.S61181","volume":"9","author":"IW Jung","year":"2014","unstructured":"Jung IW, Han HK (2014) Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro\/in vivo characterization. Int J Nanomedicine 9:2299\u20132306. https:\/\/doi.org\/10.2147\/IJN.S61181","journal-title":"Int J Nanomedicine"},{"key":"4786_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","volume":"413","author":"S Kakkar","year":"2011","unstructured":"Kakkar S, Kaur IP (2011) Spanlastics-a novel nanovesicular carrier system for ocular delivery. Int J Pharm 413:202\u2013210. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.027","journal-title":"Int J Pharm"},{"key":"4786_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106665","volume":"195","author":"BA Khan","year":"2024","unstructured":"Khan BA, Ahmad N, Alqahtani A et al (2024) Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: physical characterization and in vivo evaluation. Eur J Pharm Sci 195:106665. https:\/\/doi.org\/10.1016\/j.ejps.2023.106665","journal-title":"Eur J Pharm Sci"},{"key":"4786_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejps.2015.11.011","volume":"82","author":"JS Kim","year":"2016","unstructured":"Kim JS, Jang SW, Son M et al (2016) Enteric-coated tablet of risedronate sodium in combination with phytic acid, a natural chelating agent, for improved oral bioavailability. Eur J Pharm Sci 82:45\u201351. https:\/\/doi.org\/10.1016\/j.ejps.2015.11.011","journal-title":"Eur J Pharm Sci"},{"key":"4786_CR32","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/jbmr.147","volume":"25","author":"K Kusamori","year":"2010","unstructured":"Kusamori K, Katsumi H, Abe M et al (2010) Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis. J Bone Miner Res 25:2582\u20132591. https:\/\/doi.org\/10.1002\/jbmr.147","journal-title":"J Bone Miner Res"},{"key":"4786_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/1759720X17732562","volume":"9","author":"WF Lems","year":"2017","unstructured":"Lems WF, Raterman HG (2017) Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs. Ther Adv Musculoskelet Dis 9:299\u2013316. https:\/\/doi.org\/10.1177\/1759720X17732562","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4786_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-025-00269-2","author":"H Liang","year":"2025","unstructured":"Liang H, Chen S, Shi M et al (2025) Global epidemiology and burden of osteoporosis among postmenopausal women: insights from the Global Burden of Disease Study 2021. NPJ Aging. https:\/\/doi.org\/10.1038\/s41514-025-00269-2","journal-title":"NPJ Aging"},{"key":"4786_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115407","author":"MR McClung","year":"2020","unstructured":"McClung MR, Ebetino FH (2020) History of risedronate. Bone. https:\/\/doi.org\/10.1016\/j.bone.2020.115407","journal-title":"Bone"},{"key":"4786_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.sjbs.2021.08.088","volume":"29","author":"L Mo","year":"2022","unstructured":"Mo L, Lu G, Ou X, Ouyang D (2022) Formulation and development of novel control release transdermal patches of carvedilol to improve bioavailability for the treatment of heart failure. Saudi J Biol Sci 29:266\u2013272. https:\/\/doi.org\/10.1016\/j.sjbs.2021.08.088","journal-title":"Saudi J Biol Sci"},{"key":"4786_CR37","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902023e22643","author":"CD Modi","year":"2023","unstructured":"Modi CD, Bharadia P (2023) In-vitro and ex-vivo evaluation of transfersomal gel of methotrexate. Braz J Pharm Sci. https:\/\/doi.org\/10.1590\/s2175-97902023e22643","journal-title":"Braz J Pharm Sci"},{"key":"4786_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijpharm.2011.07.027","volume":"419","author":"SH Nam","year":"2011","unstructured":"Nam SH, Xu YJ, Nam H et al (2011) Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. Int J Pharm 419:114\u2013120. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.027","journal-title":"Int J Pharm"},{"key":"4786_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21207623","volume":"21","author":"JY Noh","year":"2020","unstructured":"Noh JY, Yang Y, Jung H (2020) Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci 21:1\u201322. https:\/\/doi.org\/10.3390\/ijms21207623","journal-title":"Int J Mol Sci"},{"key":"4786_CR40","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.msec.2017.03.147","volume":"76","author":"M Pasqualone","year":"2017","unstructured":"Pasqualone M, Andreetta HA, Cortizo MS (2017) Risedronate transdermal delivery system based on a fumaric copolymer for therapy of osteoporosis. Mater Sci Eng C Mater Biol Appl 76:652\u2013658. https:\/\/doi.org\/10.1016\/j.msec.2017.03.147","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"4786_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2024.100440","author":"S Pathak","year":"2024","unstructured":"Pathak S, Sahu P, Begum JPS et al (2024) Formulation and assessment of penetration potential of risedronate chitosan nanoparticles loaded transdermal gel in the management of osteoporosis: in vitro and ex vivo screening. Carbohydr Polym Technol Appl. https:\/\/doi.org\/10.1016\/j.carpta.2024.100440","journal-title":"Carbohydr Polym Technol Appl"},{"key":"4786_CR42","doi-asserted-by":"publisher","unstructured":"Russell RGG (2006) Bisphosphonates: from bench to bedside. In: Annals of the New York Academy of Sciences. Blackwell Publishing Inc., pp 367\u2013401. https:\/\/doi.org\/10.1196\/annals.1346.041","DOI":"10.1196\/annals.1346.041"},{"key":"4786_CR43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/1061186X.2023.2274805","volume":"31","author":"H Saini","year":"2023","unstructured":"Saini H, Rapolu Y, Razdan K et al (2023) Spanlastics: a novel elastic drug delivery system with potential applications via multifarious routes of administration. J Drug Target 31:999\u20131012. https:\/\/doi.org\/10.1080\/1061186X.2023.2274805","journal-title":"J Drug Target"},{"key":"4786_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02772-0","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. https:\/\/doi.org\/10.1186\/s13018-021-02772-0","journal-title":"J Orthop Surg Res"},{"key":"4786_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13346-020-00814-4","volume":"11","author":"NM Sallam","year":"2021","unstructured":"Sallam NM, Sanad RAB, Ahmed MM et al (2021) Impact of the mucoadhesive lyophilized wafer loaded with novel carvedilol nano-spanlastics on biochemical markers in the heart of spontaneously hypertensive rat models. Drug Deliv Transl Res 11:1009\u20131036. https:\/\/doi.org\/10.1007\/s13346-020-00814-4","journal-title":"Drug Deliv Transl Res"},{"key":"4786_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106173","volume":"101","author":"ME Sayyed","year":"2024","unstructured":"Sayyed ME, Hatem S (2024) Fluidized spanlastics for intranasal brain delivery of lacosamide aiming to control status epilepticus: design, characterization, ex-vivo permeation, radioiodination and in-vivo biodistribution studies. J Drug Deliv Sci Technol 101:106173. https:\/\/doi.org\/10.1016\/j.jddst.2024.106173","journal-title":"J Drug Deliv Sci Technol"},{"key":"4786_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882241","author":"Y Shen","year":"2022","unstructured":"Shen Y, Huang X, Wu J et al (2022) The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990\u20132019. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2022.882241","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4786_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/801820","volume":"2014","author":"H Shrestha","year":"2014","unstructured":"Shrestha H, Bala R, Arora S (2014) Lipid-based drug delivery systems. J Pharm 2014:1\u201310. https:\/\/doi.org\/10.1155\/2014\/801820","journal-title":"J Pharm"},{"key":"4786_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen T, Ozisik L, Calik Basaran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46\u201356. https:\/\/doi.org\/10.5152\/eurjrheum.2016.048","journal-title":"Eur J Rheumatol"},{"key":"4786_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123335","author":"N Sultana","year":"2023","unstructured":"Sultana N, Ali A, Waheed A et al (2023) Dissolving microneedle transdermal patch loaded with risedronate sodium and ursolic acid bipartite nanotransfersomes to combat osteoporosis: optimization, characterization, in vitro and ex vivo assessment. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123335","journal-title":"Int J Pharm"},{"key":"4786_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijpharm.2015.02.012","volume":"483","author":"SA Tayel","year":"2015","unstructured":"Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH (2015) Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. Int J Pharm 483:77\u201388. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.012","journal-title":"Int J Pharm"},{"key":"4786_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajps.2018.05.007","volume":"14","author":"S Verma","year":"2019","unstructured":"Verma S, Utreja P (2019) Vesicular nanocarrier based treatment of skin fungal infections: potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci 14:117\u2013129. https:\/\/doi.org\/10.1016\/j.ajps.2018.05.007","journal-title":"Asian J Pharm Sci"},{"key":"4786_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106088","author":"N Wafiq Mohamed","year":"2024","unstructured":"Wafiq Mohamed N, Sabry SA, Mahdy MA, Faisal MM (2024) Tailoring of spanlastics for promoting transdermal delivery of irbesartan: in vitro characterization, ex vivo permeation and in vivo assessment. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2024.106088","journal-title":"J Drug Deliv Sci Technol"},{"key":"4786_CR54","doi-asserted-by":"publisher","unstructured":"Zaki RM, Ibrahim MA, Alshora DH, Abou El Ela AES (2022) Formulation and evaluation of transdermal gel containing tacrolimus-loaded spanlastics: in vitro, ex vivo and in vivo studies. Polymers (Basel) 14. https:\/\/doi.org\/10.3390\/polym14081528","DOI":"10.3390\/polym14081528"},{"key":"4786_CR55","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.2147\/IJN.S119286","volume":"11","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Ouyang WQ, Wei YP et al (2016) Effects of Carbopol\u00ae 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study. Int J Nanomedicine 11:5971\u20135987. https:\/\/doi.org\/10.2147\/IJN.S119286","journal-title":"Int J Nanomedicine"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04786-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:51:36Z","timestamp":1775458296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04786-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04786-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Animal Ethics Committee of NMIMS University in Mumbai, India (Protocol number: CCSEA\/IAEC\/P-64\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript has been read and approved by all the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}